Get the Stockscreener App
5.16
7.86%
-0.44
Pre-market:
5.06
-0.10
-1.94%
Avita Medical Inc Stock (RCEL) Forecast
The Avita Medical Inc (RCEL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.1249, representing a +38.08% increase from the current price of $5.16. The highest analyst price target is $10.33, and the lowest is $3.9188.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RCEL Price Target
Average 5.2296
(+1.35% Upside)
Is Avita Medical Inc (RCEL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 62.70 | Neutral |
| STOCH(9,6) | 89.52 | Sell |
| STOCHRSI(14) | 74.06 | Neutral |
| MACD(12,26) | 0.1851 | Buy |
| ADX(14) | 26.48 | Buy |
| William %R | -29.74 | Neutral |
| CCI(14) | 139.94 | Buy |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.457
Buy
|
4.6731
Buy
|
| MA20 |
4.1765
Buy
|
4.4529
Buy
|
| MA50 |
4.3996
Buy
|
4.3278
Buy
|
| MA100 |
4.0358
Buy
|
4.3318
Buy
|
| MA200 |
4.4764
Buy
|
5.0731
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, RCEL could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 1 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on RCEL, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 62.7 indicates that RCEL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 89.52 indicates that RCEL is oversold. This means that RCEL price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 74.06 indicates that RCEL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.48 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 139.94 indicates that RCEL is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term RCEL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Avita Medical Inc financial reports and earnings history, Avita Medical Inc (RCEL) stock could reach $13.62 by 2030, $12.51 by 2040 and $52.52 by 2050. See the projected annual prices until 2050 of the Avita Medical Inc stock below:
- Avita Medical Inc (RCEL) is expected to reach an average price of $4.0416 in 2035, with a high prediction of $5.604 and a low estimate of $3.8172. This indicates an $-21.67% rise from the last recorded price of $5.16.
- Avita Medical Inc (RCEL) stock is projected to chart a bullish course in 2040, with an average price target of $11.51, representing an $123.12% surge from its current level. The forecast ranges from a conservative $12.74 to a sky-high $12.51.
- Our analysts predict Avita Medical Inc (RCEL) to jump 627.58% by 2045, soaring from $36.79 to an average price of $37.54, potentially reaching $36.88. While $36.79 is the low estimate, the potential upside is significant.
- Avita Medical Inc (RCEL) stock is expected to climb by 2050, reaching an average of $52.76, a $922.44% jump from its current level. However, a wide range of estimates exists, with high and low targets of $52.52 and $51.71, respectively, highlighting the market's uncertainty.
Avita Medical Inc Stock (RCEL) Year by Year Forecast
Avita Medical Inc Stock (RCEL) Price Forecast for 2026
The predicted value for Avita Medical Inc (RCEL) in 2026 is set at an average of $7.2403. Estimates vary from a peak of $13.17 to a trough of $1.3108, indicating an +40.32% surge from the present price of $5.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2026 | $6.4144 | $3.9188 | $10.33 | +24.31% |
| June, 2026 | $6.2755 | $4.2299 | $7.3922 | +21.62% |
| July, 2026 | $6.0045 | $4.4345 | $6.6233 | +16.37% |
| August, 2026 | $4.5757 | $2.6279 | $5.2923 | -11.32% |
| September, 2026 | $5.6647 | $4.6235 | $8.2213 | +9.78% |
| October, 2026 | $5.0059 | $4.4981 | $5.9725 | -2.99% |
| November, 2026 | $6.4671 | $2.6815 | $6.9671 | +25.33% |
| December, 2026 | $4.2261 | $3.1084 | $7.5149 | -18.10% |
Avita Medical Inc Stock (RCEL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Avita Medical Inc (RCEL) is $3.3855, with a high forecast of $6.6429 and a low forecast of $0.1281. This indicates an -34.39% decrease from the last price of $5.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.8473 | $3.5095 | $4.7439 | -25.44% |
| February, 2027 | $1.8685 | $1.8185 | $6.6429 | -63.79% |
| March, 2027 | $0.6825 | $0.1281 | $2.0963 | -86.77% |
| April, 2027 | $2.3414 | $1.2398 | $1.2664 | -54.62% |
| May, 2027 | $3.3302 | $3.1036 | $2.858 | -35.46% |
| June, 2027 | $2.4912 | $2.6612 | $3.2146 | -51.72% |
| July, 2027 | $3.59 | $4.6178 | $3.9578 | -30.43% |
| August, 2027 | $5.1288 | $3.6722 | $4.2388 | -0.60% |
| September, 2027 | $5.9498 | $5.861 | $5.9376 | +15.31% |
| October, 2027 | $6.8486 | $6.007 | $5.9886 | +32.73% |
| November, 2027 | $5.1974 | $6.2074 | $6.1852 | +0.73% |
| December, 2027 | $3.7784 | $4.1184 | $5.314 | -26.77% |
Avita Medical Inc Stock (RCEL) Price Forecast for 2028
In 2028, Avita Medical Inc (RCEL) is projected to reach an average price of $4.9319, with a high projection of $9.267 and a low estimate of $0.5967. This indicates an -4.42% fall from the last price of $5.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.6472 | $4.3506 | $4.4872 | -9.94% |
| February, 2028 | $5.3661 | $4.5917 | $4.9661 | +3.99% |
| March, 2028 | $5.5071 | $5.5171 | $5.5905 | +6.73% |
| April, 2028 | $3.5159 | $3.5337 | $5.2143 | -31.86% |
| May, 2028 | $3.2069 | $3.4147 | $3.3081 | -37.85% |
| June, 2028 | $1.1457 | $2.2757 | $3.1791 | -77.80% |
| July, 2028 | $0.5145 | $0.6301 | $0.3055 | -90.03% |
| August, 2028 | $3.9445 | $0.5967 | $5.4045 | -23.56% |
| September, 2028 | $5.7857 | $3.1623 | $5.7957 | +12.13% |
| October, 2028 | $7.4069 | $4.5991 | $7.9269 | +43.54% |
| November, 2028 | $4.9459 | $1.7003 | $7.3747 | -4.15% |
| December, 2028 | $8.477 | $4.6236 | $9.267 | +64.28% |
Avita Medical Inc Stock (RCEL) Price Forecast for 2029
The 2029 price forecast for Avita Medical Inc Stock (RCEL) is $7.4499 on average, with a high prediction of $13.31 and a low estimate of $1.5854. This represents an +44.38% increase from the previous price of $5.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $11.96 | $6.4326 | $13.31 | +131.71% |
| February, 2029 | $7.8372 | $7.4672 | $11.81 | +51.88% |
| March, 2029 | $8.0484 | $7.1606 | $8.655 | +55.98% |
| April, 2029 | $2.7396 | $2.2007 | $8.1362 | -46.91% |
| May, 2029 | $3.8086 | $1.5854 | $5.0286 | -26.19% |
| June, 2029 | $3.9498 | $2.6492 | $6.2664 | -23.45% |
| July, 2029 | $6.621 | $3.8976 | $7.651 | +28.31% |
| August, 2029 | $9.90 | $5.1188 | $10.46 | +91.86% |
| September, 2029 | $10.43 | $8.7012 | $11.83 | +102.15% |
| October, 2029 | $9.2601 | $9.0101 | $12.31 | +79.46% |
| November, 2029 | $2.4013 | $2.2613 | $10.27 | -53.46% |
| December, 2029 | $11.45 | $1.8191 | $10.50 | +121.90% |
Avita Medical Inc Stock (RCEL) Price Forecast for 2030
Avita Medical Inc Stock (RCEL) is expected to reach an average price of $9.7758 in 2030, with a high forecast of $19.45 and a low forecast of $0.0998. This signifies an +89.45% surge from the last price of $5.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $14.27 | $8.1588 | $13.62 | +176.59% |
| February, 2030 | $9.3396 | $9.9352 | $12.08 | +81.00% |
| March, 2030 | $12.96 | $9.894 | $10.01 | +151.11% |
| April, 2030 | $8.7749 | $8.9249 | $10.76 | +70.06% |
| May, 2030 | $1.3531 | $1.0531 | $4.6119 | -73.78% |
| June, 2030 | $6.1855 | $0.2601 | $11.29 | +19.87% |
| July, 2030 | $1.4135 | $1.9865 | $11.67 | -72.61% |
| August, 2030 | $7.6458 | $0.0998 | $7.9958 | +48.18% |
| September, 2030 | $9.8282 | $5.4782 | $11.34 | +90.47% |
| October, 2030 | $18.26 | $6.365 | $18.61 | +253.80% |
| November, 2030 | $5.9114 | $0.2974 | $19.45 | +14.56% |
| December, 2030 | $7.779 | $5.3246 | $10.22 | +50.76% |
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):